FDA Announces Audio Broadcasts on Emerging Drug Safety Information
...mbing products used in hair removal; the voluntary market withdrawals of drugs to treat the symptoms of Parkinson's disease and irritable bowel syndrome, and to serious adverse events associated with agents that reduce the need for blood transfusions in cancer patients. The American Medical Association (A...Asian Business Executives Urged to Be Eco-friendly
...lective security, he added. Delegates focused on market risks and business opportunities resulting from environmental change. Among the risks that businesses face is "how to factor in climatic change," Steiner said. Looking ahead, he cited the predictability of biofuels. "We are seeing rising waters, ...Geisinger Launches Extensive Study on Obesity and Related Liver Problem
...ve blood test for the disease and then bring it to market so other physicians can use it, said Geisinger staff scientist Glenn S. Gerhard, MD. To that end, Geisinger is uniquely positioned to develop such a test because of the array of resources the system has at its disposal. Geisinger has collected mo...Chondroitin may Not Have Any Beneficial Effect on Arthritis, New Study Says
...for chondroitin and glucosamine. The U.S. consumer market for glucosamine and chondroitin pills, almost always sold in combination, was 810 million dollars in 2005, notes Katja Rauhala, research manager with the Nutrition Business Journal. Andrew Shao, vice president of scientific and regulatory affairs w...India's Pharmaceutical Industry to Be Global Player: Study
...ising rapidly," Singer said, adding that the world market for generics was expected to increase significantl...on, however, that the lure of profits on the world market could distract attention from research into illnesses typical of developing countries. The study w...South African Farmers Turn to Organic Farming
... chains to the tonier Woolworths. In an emerging market such as South Africa the move to organic productio...n ideologically driven decision. With the global market for organic food growing at a runaway 35 percent, new suppliers are being urgently sought, particula...Infections in UK Hospitals Drive British Patients to India
...approximately pounds 2,500 each, with an estimated market value of over pounds 50 million a year. Cosmetic...ng around pounds 3,500 each, creating an estimated market worth pounds 50 million. The most common types of elective surgery for patients travelling abroad ...Hip Resurfacing Fever Catches on in US
...Institute of Chicago. The operation hit the U.S. market last spring with Food and Drug Administration approval of the British-designed Birmingham Hip Resurfacing System. Competitors are in clinical trials here, and expected to clear FDA later this year. More than 400,000 total or partial hip replacement...UK Scientists to Reveal Genetic Secrets Behind Serious Illnesses
...rs that testing will fuel the fledgling commercial market for genetic testing and that people will not receive the counselling required to react to a positive result for an illness. /V...Merck's Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
...) has rejected pharmaceutical giant Merck's bid to market Arcoxia,// a new osteoarthritis medication followi...pull yet another CoX-2 inhibitor Vioxx from the US market in 2004, also following evidence that it increased the patients' risk of heart attacks and strokes. ...India’s Biotech Companies- Jumbos Waiting to Gro
...e, it is well known that India’s IT firms have won market share in everything from data analysis to call centers. Says Singer: "At the moment we think of biotech in India as the baby elephant where information technology is the adult elephant. But that baby elephant is going to grow. "Any biotech or bi...FDA Announces to Companies to Stop Marketing Products Containing Trimethobenzamide
...til supplies are exhausted. Any company wishing to market a product containing trimethobenzamide in suppository form must now obtain an approved new drug application prior to marketing. This action is the next step in a concerted FDA effort to ensure that all marketed U.S. drugs have required FDA approva...Law Emerging in US for Generic Versions of Biotech Medicine
...p 20 percent from 2005, according to IMS Health, a market research company. More than 400 biotech products are in the pipeline, for more than 100 diseases, including cancer, AIDS, diabetes and Alzheimer’s. But then the bio-tech drugs are prohibitively expensive. A year's worth of Genzyme's (DNA) Cerezyme...Food Industry in India to Grow to $310 Billion by 2015: CII
...food brands are rapidly entering the global retail market and a breed of foreign taste masters are currently operating in India. The global food industry is also expected to witness major growth and expansion as more and more countries are replacing the tariff barriers with non-tariff barriers to maintain...United Biotech Launches New Oncology Division
...his launch, the company intends to manufacture and market molecules that are currently being exclusively marketed by multinationals. The company also intends to offer the products at a much lower price than that offered by the multinationals. “To funnel our short term growth plan in the oncology segment...Ibuprofen Risky for Heart Patients?
...004, Merck voluntarily withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use. Rofecoxib was one of the most widely used drugs ever to be withdrawn from the market. The study by Farkouh and colleagues enrolled 18,3...Outsourcing Farming, a Chinese Initiative
... reports say. 'All of a sudden you have a global market for land, a competition between several different products for the same amount of land,' said Sergio Barroso, president for the Brazil operations of Cargill, the biggest grain trader in the world. Brazil’s soybean industry is losing acres to sugar ca...Drug Company Halts Late-Stage Trial of Sickle-Cell Disease Drug
...and Johnson & Johnson -- which paid $15 million to market and help develop the drug -- at that point decided to adjust the number of participants and treatment options being tested in the trial. Recently, the committee said preliminary trial data show that senicapoc does not prevent chronic pain, one of ......tones. Pfizer will have an exclusive license to market all products developed as part of this research collaboration in ophthalmic applications and will pay pSivida a royalty on net sales of those products. In addition to the development and sales milestones and payment of the cost of the joint resear...